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Trening er medisin:  
Optimal utholdenhets og styrketrening hos koronar pasienter og friske mennesker  
 
Intervalltrening med høy aerob intensitet ved 90-95% av maksimal hjerte frekvens er mer effektiv enn 
kontinuerlig trening med lav til moderat intensitet for å forbedre maksimalt oksygenopptak blant friske 
unge menn. Maksimalt hjerteminuttvolum økte i samme omfang som maksimalt oksygenopptak, men 
bare i gruppene som trente høy aerob intensitets intervall trening. Høy aerob intensitets 
utholdenhetstrening er signifikant mer effektivt enn trening på laktatterskel (85% av maksimal 
hjertefrekvens) og på 70% av maksimal hjertefrekvens, for å øke maksimalt oksygenopptak og hjertets 
slagvolum. Økningen i maksimalt oksygenopptak korresponderer med forandringer i slagvolum, og 
indikerer at det eksisterer en nær sammenheng mellom disse to parametrene.  
 
Høy aerob intensitets intervall trening på 85-95% av peak hjerte frekvens gir en signifikant økning i 
hjertets slagvolum samt venstre ventrikkels ejeksjonsfraksjon i pasienter med koronar hjertesykdom. 
Høy aerob intensitets intervall trening øker hjertets peak slagvolum og venstre ventrikkels 
ejeksjonsfraksjon som en funksjon av økt myokard kontraktilitet og bedring i venstre ventrikkels 
systoliske funksjon.  
 
Intervall trening i hyperoksi (100% oksygen) gav ingen effekt utover intervall trening i normoksi (21% 
oksygen) hos pasienter med koronar hjertesykdom med mild til moderat iskemi. Trening i hyperoksi 
økte VO2peak og peak slagvolum tilsvarende som trening i normoksi. Ettersom akutt eksponering til 
hyperoksi ikke forbedret VO2peak konkluderes det med at koronarpasienter har en perifer oksygen 
begrensning for VO2peak i forkant og i etterkant av 10 uker med trening i hyperoksi.  
 
Trening av maksimal legg press med fokus på få repetisjoner med tung belastning og maksimal 
konsentrisk kontraksjon øker maksimal muskel styrke, kraftutviklingshastighet, og mekanisk gang 
effektivitet hos koronarpasienter gjennom et minimum av trening. Økning i muskelstyrke og 
kraftutviklingshastighet kan overføres til bedret mekanisk effektivitet under gang, tilsvarende friske 
menn i samme aldersgruppe.  
 
Bakgrunnen for å gjennomføre studiene var et ønske om å undersøke effekten av utholdenhetstrening 
med ulik intensitet og varighet, men med identisk energiforbruk. I tillegg ønsket vi å undersøke nye 
aspekter og mekanismer knyttet til intervalltrening med høy aerob intensitet blant hjertepasienter, samt 
å undersøke effekten av maksimal styrketrening på muskestyrke, reaksjonshastighet og submaksimal 
utholdenhet i denne pasientgruppen. Studiene i denne avhandlingen er gjennomført som kontrollerte 
treningsintervensjoner, men testing av blant annet utholdenhet, muskelstyrke og hjertefunksjon i 
forkant og etterkant av en 8-10 ukers treningsperiode.        
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Definitions 
 
Maximal oxygen uptake (VO2max): The highest oxygen uptake achieved during dynamic 
exercise with large muscle groups. VO2max is by most authors regarded as the best single 
measure of aerobic endurance.  
 
Peak oxygen uptake (VO2peak): The highest oxygen uptake achieved in a patient population 
where all the criteria for VO2max cannot be fulfilled.   
 
Mechanical work efficiency: The efficiency of skeletal muscles to transform biomechanical 
energy into the external work of movement. 
 
Work Economy: The ratio between oxygen cost and exercise load.  
 
Lactate threshold: The level of exercise where equilibrium between production and removal 
of lactate exists.  
 
Cardiac output (CO): The volume of blood ejected into the main artery by each ventricle. 
Normally cardiac output is expressed as litres per minute. Both ventricles eject the same 
amount of blood with only small fluctuations.     
 
Stroke Volume (SV): The volume of blood ejected from the ventricle into the main artery 
each heart beat. Normally stroke volume is calculated through dividing the cardiac output by 
the heart rate.  
 
Ejection fraction (EF): The percentage of the end diastolic volume ejected as stroke volume.   
 
Maximal muscular strength:  A muscles maximal potential to develop force.    
 
Rate of force development: The ability to produce force per time unit.  
 
Hyperoxia: Inspiration of a gas mixture with an oxygen content exceeding ambient air.  
 
 
Abbreviations  
 
VO2max  Maximal oxygen uptake  
VO2peak  Peak oxygen uptake 
a-vO2 difference  Arterio-venous oxygen difference  
1RM   One repetition maximum 
PO2   Partial pressure of oxygen  
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Summary 
High aerobic intensity interval training at 90-95% of maximal heart rate is more effective than 
continuous training with low to moderate intensity in improving maximal oxygen uptake in 
healthy young men. Maximal cardiac stroke volume was improved to a similar extent in high 
aerobic intensity interval training only. It is concluded that high aerobic intensity endurance 
training is significantly more effective than isocaloric training at lactate threshold (85% of 
maximal heart rate) or 70% of maximal heart rate, in improving maximal oxygen uptake and 
cardiac stroke volume. Improvements in maximal oxygen uptake corresponded with changes 
in stroke volume, indicating a close link between the two.  
 
High aerobic intensity interval training at 85-95% of peak heart rate significantly improves 
peak cardiac stroke volume and resting left ventricular ejection fraction in coronary artery 
disease patients. High aerobic intensity interval training improves peak cardiac stroke volume 
and left ventricular ejection fraction in coronary artery disease patients due to increased 
myocardial contractility and enhanced left ventricular systolic performance. 
 
Hyperoxic high aerobic intensity interval training at 85-95% of peak heart rate gave no 
additional effect over normoxic high aerobic intensity interval training in coronary artery 
disease patients. Hyperoxic training improves VO2peak and peak stroke volume to the same 
extent as ambient air training in stable coronary artery disease patients with mild to moderate 
coronary ischemia. As acute hyperoxia did not increase VO2peak it is concluded that the 
coronary artery disease patients showed peripheral oxygen limitations in VO2peak both before 
and after 10 weeks of hyperoxic training. Hyperoxic training may thereby represent no 
increase in cardiovascular shear stress.   
 
Maximal leg press exercise focusing on few repetitions with heavy loads and maximal 
concentric contractions improves maximal strength, rate of force developments and walking 
mechanical efficiency in coronary artery disease patients through a minimal exercise effort. 
Improved muscular strength and rate of force development translates into improved walking 
mechanical efficiency returning the patients work efficiency to the levels of healthy age 
matched subjects.   
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1 Introduction  
Maximal oxygen uptake (VO2max) has been named the prognostic variable that does not get 
enough attention in cardiac medicine. This in spite of the history of epidemiology research 
documenting the importance of physical training as a protecting agent for the development of 
cardiovascular disease, ranging from the early Greek philosophers to the modern 
epidemiology work introduced by professor Jeremy N. Morris in the 1950’s [101, 127].  
 
Cardiovascular disease includes the diagnosis hypertension, ischemic heart disease, stroke, 
arrhythmia, congestive heart disease and valvular disease. The most common form of heart 
disease is coronary heart disease most often caused by atheroma and complications following 
thereafter, and thrombosis in particular [197]. Coronary artery stenosis impair myocardial 
blood flow leading to ischemia, reduced myocardial contractile function and may eventually 
result in myocardial infarction and death [161]. The cardinal symptoms of coronary heart 
disease are dyspnoea, chest pain or discomfort, cyanosis, syncope, palpitation and edema, 
together with dyspnoea and fatigue at low effort [135, 197].  
 
Cardiovascular disease is the dominant chronic disease accounting for ~50% of all deaths in 
developed countries [197]. Coronary heart disease is the leading cause of death, and a major 
cause of physical disability in the United States [2]. By the year 2020 cardiovascular disease 
is predicted to be the number one cause of death and disability accounting for one in every 
three deaths, claiming 25 million lives annually. Cardiovascular disease requires expensive 
treatment, pharmaceuticals alone costing $36 billion in the United States in 2001, counting for 
19% of all drug costs [197]. Despite major advances in pharmacological treatment a number 
of heart failure patients suffer from dyspnoea, fatigue, reduced exercise capacity and poor 
quality of life [177], and a higher prevalence of disability is reported compared with healthy 
age matched individuals [138].  
1.1 Aerobic endurance 
Aerobic endurance is defined as the ability to perform large-muscle, whole body exercise at 
moderate to high intensities for extended periods of time [129]. Aerobic endurance depends 
on the supply of oxygen and nutrients to the working muscles, the muscles ability to 
metabolise nutrients and the removal of metabolites produced [199]. VO2max, anaerobic 
threshold and work economy or efficiency (i.e. the oxygen cost to generate a given work load) 
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has been identified as the primary influencing factors to aerobic endurance performance [87, 
129].  
1.2 Maximal oxygen uptake  
Maximal oxygen uptake is in most publications regarded the single best predictor of aerobic 
endurance [96], defined as the highest oxygen uptake an individual may attain during exercise 
engaging large muscle groups while breathing air at sea level [129, 200]. VO2max is largely 
determined by maximal cardiac output, the oxygen carrying capacity of the blood and the 
oxidative capacity of the active skeletal muscle tissue [87, 129]. VO2max can be displayed as 
( )   differencevO-a SVHRVO  22max ⋅⋅= ,where heart rate (HR) times stroke volume (SV) 
equals cardiac output (QO) and the arterio-venous oxygen difference (a-vO2 difference) is the 
difference in oxygen content in arterial and venous blood [12]. Oxygen uptake increases 
linearly with increasing power output [182]. For each litre of oxygen consumed, about 5 
kilocalories of energy output will be delivered, thereby a greater oxygen uptake results in a 
larger aerobic energy output [199]. VO2max is a good predictor of endurance sport 
performance [156], and are exercise specific with 10 - 20% lower VO2max observed in 
stationary biking compared to treadmill exercise [111]. Variability in VO2max are observed 
due to body size, muscle mass, genetics, age, gender and conditioning status [87, 129]. The 
term peak oxygen uptake (VO2peak) is more commonly used to express exercise capacity in 
patients with cardiovascular and pulmonary disease due to inability to achieve the VO2max 
criteria [12].                                                                                                                                                           
1.3 VO2max , aging and inactivity  
VO2max is dictated by the health and efforts of the pulmonary, cardiovascular and skeletal 
muscle system, and reflects the ability to perform day to day activities [12]. The 
cardiovascular systems functional capacity declines with aging [151, 166, 173, 191, 200] and 
inactivity [105], on average 10% per decade in healthy adults [173]. It is debated whether 
reduced VO2max is due to aging itself or a decrease in activity level [191]. Lifelong endurance 
training forestalls the age related reduction in VO2max [89, 152], resulting in higher VO2max 
than in inactive age matched individuals, and values comparable to untrained young men [25]. 
VO2max may be reduced with age in physically active men as well, but remains higher at all 
ages compared to inactive individuals [191]. 3 weeks of complete inactivity dramatically 
reduce VO2max to the same level as 30 years of aging [105]. The age-related decline in VO2max 
may be caused by the maximal cardiac output or the a-vO2 difference, with maximal oxygen 
delivery most likely the major contributor to the age-related decline in VO2max [173].  
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1.4 Cardiopulmonary exercise testing  
Cardiopulmonary exercise testing may bring forth cardiovascular abnormalities not present at 
rest. Together with electrocardiography it is the most frequent non-invasive diagnostics of 
coronary artery disease [197], and a good predictor of health status and prognosis [136]. 
Exercise testing is considered safe in most cardiovascular disease populations with a mortality 
and morbidity of less than 0.01 and 0.05 percent respectively [197].  
1.5 Safety of testing and training  
Vigorous physical activity acutely increases the risk of myocardial infarction and sudden 
cardiac death in susceptible individuals. Exercise related cardiac events may occur in 
individuals with structural cardiac disease. The risk is greatest after an acute ischemic event 
[197], and atherosclerotic disease is often the main triggering factor [176]. The incidence of 
myocardial infarction and sudden death is greatest in the habitually least physically active 
individuals and in subjects with low physical fitness [23, 47, 114, 128, 144, 176], while 
regular physical activity reduce the incidence of cardiovascular events [114, 128] and 
mortality [23, 114, 128]. High MET levels (1MET = 3.5 ml. kg-1. min-1) is inversely associated 
with prevalence of carotid atherosclerosis in hypertensive men [85], and the incidence of 
cardiac arrest decrease with increasing level of habitual activity [163]. Improvements in risk 
factors associated with coronary artery disease may prove important for death risk and the 
development of cardiovascular disease [175]. Thereby it is essential not to overestimate the 
risk of training since the benefits outweigh the risk [176]. Heart failure patients may safely 
take part in exercise training and thereby reduce mortality risk and hospital admission rate 
[137].   
1.6 Mortality  
VO2max is an important predictor for cardiovascular and all cause mortality and morbidity. 
High VO2max corresponds with lower death rates in all age groups [57, 113, 117], and are 
together with exercise energy expenditure an important predictor of all-cause and 
cardiovascular mortality [116]. An improvement in VO2max by 1 MET (3.5 ml. kg-1. min-1) 
may improve the risk of mortality by as much as 12-17% [57, 117]. Training significantly 
reduce clinical events [106], mortality and hospital admission rates in heart failure patients [4, 
137]. Patients enrolled in cardiovascular exercise programs reduces cardiovascular deaths by 
20-25% whereas the occurrence of cardiac events is more frequent in patients not training 
[19].  
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1.7 Cost of treatment  
Training after coronary artery disease events is economically favourable, reducing the costs 
associated with rehospitalization [4, 42]. Aerobic endurance training has shown superior cost 
effects compared with standard treatment. The combination of training and life style changes 
compared with percutaneous transluminal coronary angioplasty treatment proved to be twice 
as cost effective, with less cardiac events and the intervention demonstrating improvements in 
aerobic power [65]. Training has a positive economically potential in rehabilitation after 
cardiac events, as it is safe, effective and relatively pleasant treatment with moderate costs 
compared with alternative therapy [4]. The mortality and cost aspects highlights the 
importance of employing effective endurance training in treatment and prevention of 
cardiovascular disease [101], and the large direct and indirect costs of coronary artery disease 
does call for a justification of the economy of medical benefits (42).  
1.8 Endurance training  
Training entails exposing the organism to a training load or work stress of sufficient intensity, 
duration and frequency to produce structural and functional adaptations resulting in a 
noticeable measurable training effect in the function one is training [102, 199]. Endurance 
events are activities lasting for 2 minutes or more [29]. Endurance training is an effective 
means for improving VO2max, and the most striking adaptations include increased cardiac 
stroke volume and capillary- and mitochondrial density [87, 102]. Improvements in VO2max 
are related to training intensity, duration and frequency [141]. The minimum intensity for 
initiation improvements in VO2max seems to be 55-65% of maximal heart rate [200], whereas 
elevated training responses are observed with high intensity training [186]. Comparison of 
training protocols matched for total work and frequency, report high aerobic intensity interval 
training between 85 to 95% of maximal heart rate, to be more beneficial for improving 
aerobic power than continuous training at lower intensities in both healthy individuals [174] 
and cardiovascular disease patients [153, 193]. Other investigators does not detect a 
difference between continuous and interval training when the training was performed at the 
same intensity [126].  
1.9 Endurance training in coronary artery disease patients  
Reduced VO2peak is reported in heart failure patients. Similar skeletal muscle impairments as 
with physical deconditioning are observed and may influence VO2peak more than myocardial 
abnormalities [108]. The magnitude of reduction in VO2max and coronary function may also 
depend on the level of ischemia and/or the size of prior myocardial infarction [8]. Substantial 
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epidemiological, clinical and basic science suggest that physical activity and training delays 
the development of atherosclerosis, reduces the incidence of coronary heart disease events 
[176], and reverses skeletal muscle abnormities [108]. The American heart association 
supports the use of training as a means to optimize cardiovascular risk reduction and promotes 
an active lifestyle for cardiovascular disease patients [14, 175]. Training in cardiac 
rehabilitation serves as a valuable non-pharmacologic intervention improving VO2peak and 
overall health status in patients with coronary artery disease [184]. 
 
Heart failure patients significantly improves VO2peak as a result of endurance training [153, 
164, 177, 193]. Training intensity is critical for maintaining VO2peak, endurance and cardiac 
enlargement [71]. High intensity training is twice as effective in increasing VO2max as 
conventional cardiac rehabilitation programs [58], successfully improving VO2peak and health 
status in coronary artery disease patients [184]. High aerobic intensity interval training is 
superior to isocaloric moderate intensity training in improving VO2peak in cardiovascular 
disease patients [153, 193]. Neither interval training nor traditional aerobic programs 
increases the risk to the patients [184], and high intensity training maintains or improves 
cardiovascular function and the risk of further atherogenesis [58]. Endurance training elevates 
the angina threshold partly through reduced submaximal heart rate, and the long term effect of 
training may be equal to the short term effects of nitro-glycerine use [36].  
 
Aerobic endurance training initiates several cardiovascular and health benefits in addition to 
increasing VO2peak. Reductions in blood pressure, low density lipoprotein, total cholesterol 
level and body weight are reported [58, 115, 124] together with increase in high density 
lipoprotein levels, and improved endothelial function, blood glucose and insulin sensitivity 
[58]. Resting bradycardia is reported improved, peripheral venous tone increased, and plasma 
volume expands improving central blood volume and ventricular preload. Also myocardial 
contractility and stroke volume improves [162, 177, 193], together with a net reduction in 
thrombogenic risk and improved blood rheology [35, 53].  
 
Despite numerous reports and recommendations from expert panels on the importance of 
training in prevention of cardiovascular disease less than one third of Americans meet the 
minimal recommendations outlined by the centre for disease control and prevention, the 
American College of Sports Medicine and the American Heart Association [115], implying 
that the implementation of endurance training in the coronary artery disease population is 
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challenging. Only 10-20% of eligible patients participates in cardiac rehabilitation programs 
[2], and trials struggles with low long-term compliance with non medical dropout reasons [4]. 
Comparison  of supervised and home based training programs found 3 months of supervised 
training to be as effective as 12 months of home based training implying that some level of 
supervision is required for successful training management [109]. Individual programs with 
close follow up are therefore recommended as rehabilitation and secondary prevention for 
coronary heart disease patients [2]. 
1.10 Stroke Volume  
Stroke volume does not seem to plateau from rest to maximal exercise in endurance trained 
athletes, in contradiction to earlier believes [50, 54, 196]. A plateau exists at different 
submaximal levels in untrained subjects and university athletes [54, 196], with a secondary 
increase in stroke volume at heavy work loads in some cases [50]. The large stroke volumes 
recorded in endurance athletes is a results of enhanced cardiac chamber and pericardial 
compliance producing a greater end-diastolic volume or a larger left ventricle dimension [96, 
192]. The diastolic filling and left ventricle emptying rate is significantly faster in endurance 
trained athletes compared with moderately trained subjects [50]. At a heart rate of 190 beats . 
min-1 ventricular emptying and filling rate were 20% and 71% greater in elite athletes versus 
untrained subjects, making ventricular filling the athletes’ major advantage implying a 
considerably enhancement in ventricular preload and/or compliance [50, 54].  
 
The majority of evidence supports that maximal cardiac output decrease with aging through 
reduced maximal stroke volume and reduced maximal heart rate [173], and that a sedentary 
lifestyle in addition deteriorates coronary function with left ventricular stiffness, decreased 
left ventricular compliance and diastolic performance [11, 151]. Endurance trained 
individuals displays greater stroke volume, ventricular filling, systolic and diastolic left 
ventricular function and cardiac contractility compared with active and sedentary subjects [24, 
25].  
 
In coronary artery disease patients endurance training increases peak stroke volume and 
improve left ventricular function [43, 44, 58, 63]. Training reducing myocardial ischemia may 
increase left ventricle contractile function [43, 58]. Improved stroke volume and left ventricle 
ejection fraction is associated with reduced peripheral resistance and cardiomegaly [46, 63]. 
Endurance training reverse myocardial remodelling through reduced left ventricle end 
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diastolic diameter [20, 63]. Intensity dependency has been reported in the myocardial 
response to endurance training. High intensity endurance training has a greater effect on rest 
to peak left ventricular ejection fraction [123] and on reversing myocardial remodelling than 
moderate training [193]. Training and detraining in older men gives qualitatively and 
quantitatively similar changes in left ventricular performance, however directionally opposite, 
abolishing the diversity in cardiovascular performance, and highlights the importance of 
endurance training for maintaining myocardial function and capacity [160]. Preserved 
ventricular compliance in endurance training elderly may possibly prevent heart failure [11].  
1.11 Myocardial perfusion  
Endurance training may reverse the cardiovascular disease through a regression of stenosis, 
reducing the number of angina episodes [124] and decelerate the development of coronary 
artery disease [121]. Endurance training improves coronary perfusion and reduces ischemia in 
all ischemic areas while percutaneous transluminal coronary angioplasty treatment only 
improved perfusion in the treated stenosis area [90]. Increased coronary perfusion after 
endurance training in cardiovascular disease patients indicates increased microcirculation in 
the ischemic segments of the myocardium [194]. This may be a result of improved endothelial 
function and vasoregulation through elevated nitric oxide syntheses expression [61, 66] and 
regression in coronary atherosclerosis [67]. Improvements in coronary collateralization [37, 
159] and increased myocardial capillary density [187] have been observed in animal training 
models, but are still controversial in humans [20, 121]. Some authors report no difference in 
collateral formation with training [121], while other reports collateral formation with training 
[20].  
1.12 Endothelial function  
The endothelium maintains vascular homeostasis through interactions between cells in the 
vessel wall and lumen. This includes regulation of vascular tone through nitric oxide and 
other vasoconstrictors, platelet inactivity, and production of cytokines and adhesion molecules 
active in inflammation [98, 188]. Endurance training improve endothelium mediated 
vasodilatation in peripheral vasculature [62, 99], and myocardial arteries in patients with 
atherosclerosis [61, 66]. This reverses the peripheral vascular resistance caused by endothelial 
dysfunction [195].  
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1.13 Limitations to exercise  
A classic question in human physiology is which link in the body’s oxygen transport system 
that limits VO2max [155]. Some authors claim that the integrated effect of all steps in the 
respiratory cascade helps set the VO2max, since a change in any step will alter VO2max [76]. 
Current knowledge does however separate between limitations in the supply of oxygen or 
demand limitation in the peripheral skeletal muscles [12]. Muscle blood flow is closely 
related to the oxygen demand of the exercising muscles, and a large increase in muscle 
perfusion and oxygen delivery is observed during small muscle mass exercises, indicating that 
the vascular bed in skeletal muscles does not limit oxygen transport [9]. Redistribution of 
blood and capillary mean transit time is crucial for oxygen extraction and the a-vO2 
difference. During whole body exercise the cardiac output is not sufficiency large to allow for 
the same level of muscle capillary blood supply as observed during smaller muscle exercise 
[155]. Factors limiting VO2max has been thoroughly investigated with data supporting the 
notion that oxygen supply limits VO2max in the healthy human skeletal muscles [92, 147-149, 
157, 181]. A separation between supply limitation in VO2max in athletic individuals and 
metabolic limitations in VO2max in unfit subjects, with exercise training serving as a switch in 
the relationship from metabolic towards supply limitation has been suggested [182]. Patients 
with severe chronic heart failure develop depressed oxidative capacity in the skeletal muscles 
decreasing VO2peak. This implies that the functional capacity of heart failure patients is not 
merely limited by oxygen supply, but by the oxidative capacity of mitochondria in working 
muscle as well [41].  
1.14 Hyperoxia, performance and exercise  
Hyperoxia is defined as inspiration of oxygen at pressures greater than air at sea level, with no 
more than 1 atmosphere absolute pressure [185]. The oxygen supply to the skeletal muscle is 
a function of the arterial oxygen content and muscle blood flow [56]. Breathing hyperoxic gas 
increases the arterial and tissue partial pressure of oxygen (PO2) and the haemoglobin oxygen 
saturation, providing additional oxygen supply to the working skeletal muscles.  
 
Acute exposure to hyperoxia increases VO2max and performance in endurance athletes [130-
132, 145, 148], and in healthy- and untrained subjects [33, 45, 92, 139], and allows for 
training at a greater intensity compared to normoxia [134, 140]. In the trained skeletal muscle 
hyperoxia elevate intracellular PO2 and VO2max. The increase in VO2max is however 
disproportional to PO2 suggesting that the trained skeletal muscle at times may be at 
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borderline in terms of supply limitations [149]. A coronary ischemic limitation to exercise is 
defined as the angina threshold. Hyperoxia may elevate the angina threshold in heart patients, 
allowing the heart to perform more work before the development of coronary insufficiency 
[77], increasing the exercise performance [1, 77, 112, 142, 150]. Some authors recommend 
the use of hyperoxia during training to patients with angina pain [142]. Others observe no 
improvements in performance and leg oxygen consumption in heart failure patients exposed 
to hyperoxia [146, 154], probably implying some variations within the patient population. 
Two training studies have investigated the effect of hyperoxic training in healthy subjects, 
demonstration significantly increased training load, without any significant effect on VO2max 
after 5- and 6 weeks of training [134, 140].  
1.15 Skeletal Muscular Strength 
Skeletal muscle strength is defined as the integrated result of several force-producing muscles 
performing maximal isometric or dynamic contractions during a single voluntary effort in a 
defined task [73]. Maximal strength is defined as one repetition maximum (1RM) in a 
standardized movement [72], and power is a product of force inversely related to time [73]. 
The ability to create as much force as possible in the shortest possible time is named rate of 
force development. A skeletal muscle’s ability to develop force depends on several factors 
including initial position, speed of muscular- lengthening and shortening, eccentric initial 
phase, type of muscle fibres, muscle cross- sectional area, number of motor units activated 
simultaneously, impulse frequency, and substrate availability [102].  
 
Muscular strength decreases with age and inactivity [21, 95, 143, 179], and is associated with 
diminished functional capacity of the neuromuscular, neuroendocrine, cardiovascular and 
respiratory systems [83]. Reduced skeletal muscle strength is associated with reduced muscle 
mass through loss of skeletal muscle fibres secondary to decreased number of motoneurons, 
gradually aggravating health and physical function [40, 119, 143]. Reduced skeletal muscle 
strength in coronary artery disease patients may be due to long term bed rest and inactivity 
arising from the fear of the consequences of training. Inactivity leads to deconditioning and 
progressively reduced skeletal muscle strength and volume [120]. Skeletal muscle atrophy has 
been observed in heart failure patients [100], and the prevalence of sarcopenia may be as high 
as 30% in the above 60 year old population [40]. Sarcopenia and reduced neuromuscular 
function may explain lower maximal skeletal muscle strength in heart patients compared with 
healthy subjects [30, 100]. In coronary artery disease patients reduced physical capacity are in 
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many cases the result of reduced skeletal muscle function, and can be unrelated to 
cardiovascular function [109]. Aging and inactivity leads to reduced muscle mass and 
increased prevalence of disability. With reduced skeletal muscular strength follows a 
progressive loss of function and capability of day to day activities, and loss of independence 
[40]. Quality of life is affected negatively by diminished muscular strength and endurance, as 
is the ability to complete physical tasks [80]. Middle age and older coronary artery disease 
patients state a greater levels of physical disability in daily life compared with healthy age 
matched individuals [138].  
 
Reduced skeletal muscle strength may also be due to reduced neuromuscular response and 
voluntary neural drive to the muscle [82, 84, 97], or high antagonist muscle activity limiting 
movement efficiency [84]. Reduced rate of force development has been demonstrated in 
healthy elderly compared with younger individuals [84, 179]. Elderly individuals with a high 
level of disuse have a marked loss of muscle mass and strength. Reduced neuromuscular 
activation, contractile function and rate of force development are more affected by disuse than 
maximal muscle strength [170]. Coronary artery disease populations have a high prevalence 
of obesity, with body mass indexes exceeding 25, in 50 to 88% of the patients [13, 27]. 
Strength training has the capability of altering the body composition from fat to muscle tissue 
[80]. Elevated body fat is associated with reduced walking speed, and functional limitations in 
daily life, while increased levels of muscle mass is associated with faster walking speed and 
less limitation to daily functionality [167]. In a cardiac rehabilitation setting weight loss is 
effective in reducing body fat and total cholesterol and scores for physical function [158].  
1.16 Strength training  
Skeletal muscular strength enhancement is made possible through muscular hypertrophy 
and/or neural adaptation. With hypertrophy the muscle fibre myofibril content increase in 
association with elevated muscular strength and body weight [55]. Strength training reverse 
sarcopedia [143, 178], inflicting hypertrophy and increase skeletal muscular strength [52]. 
Muscle atrophy is distinctive for chronic heart failure patients [180], and muscular strength is 
a strong predictor of survival in severe congestive heart failure patients [79]. With progressing 
New York Heart Association grading, muscle metabolism is aggravated, and skeletal muscle 
function seems to be one of the crucial end points in the evaluation of physical conditioning 
[10, 79, 189]. Resistance training has the potential of treating myopathy and muscle weakness 
occurring in the majority of heart failure patients [180]. Disabled older female coronary heart 
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disease patients performing resistance training increased both physical activity and total 
energy expenditure [5], together with improved muscular strength, physical capacity in 
household activities, endurance, balance, coordination and flexibility, making resistance 
training an important rehabilitation component [6]. Strength training has in some cases been 
found to improves test scores for physical function [28], and lower risk factors associated with 
coronary artery disease [15, 81] most likely through increased activity levels.  
 
Muscular strength improvement strategies without weight gain may be advantageous in the 
coronary artery disease population since transportation of a greater body mass is undesirable.  
Strength training to impose neural adaptations includes recruiting the fastest motor units 
through training with a rapid movement action. In practical terms it means that dynamic 
movements, few repetitions (three to five), heavy resistance (85-100% of 1RM) and explosive 
movements are implied [18, 93]. Maximal strength training emphasizing neural adaptations 
[17] is an effective means for improving 1RM and rate of force development in healthy 
subjects [7, 72, 74, 93, 125], and chronic constructive pulmonary disease (COPD) patients 
[75]. The improvement in skeletal muscular strength and power has been linked to neural 
adaptations and increased voluntary activation of agonists and reduced antagonist coactivation 
in elderly subjects [59, 60], leading to better walking actions [59]. Resistance training evoked 
both the V-Wave and the H-reflex responses during maximal muscle contraction, increasing 
the motoneural output that may include central motor drive, elevated motoneuron exitability 
and reduced presynaptic inhibition [198].  
1.17 Muscular strength and endurance performance  
Work economy is referred to as the ratio between work output and oxygen cost. At a standard 
running velocity individual variations in oxygen costs exist [31, 68, 69]. Mechanical work 
efficiency is defined as the efficiency of skeletal muscles to transform biomechanical energy 
into the external work of movement [133]. For healthy subjects normal walking efficiency is 
approximately 25 % [133]. The metabolic cost of walking is increased in healthy older adults 
[110], and reduced walking mechanical efficiency is found in both COPD and coronary artery 
disease patients negatively affecting walking performance [78]. The increased level of 
disability reported in coronary artery disease patients may in part be linked to reduced walking 
efficiency, diminishing the ability for day to day movements [78]. The association between 
muscular strength and endurance performance is important, given that in addition to increasing 
1RM, strength training of the legs also improves endurance performance [70].  
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Maximal strength training has been reported to improve work economy during endurance 
activities in healthy subjects by ~5-30% [72, 74, 75, 125], and mechanical work efficiency in 
COPD patients by 32% [75]. Ades et al. [3] found increased walking endurance after strength 
training in healthy elderly individuals, however this is not the case in all training studies [110]. 
A minimum of muscular strength are required to manage daily activities. The ability to rapid 
force development in skeletal muscles (i.e., contractile rate of force development) is an 
important characteristic contributing to performance of daily activities such as stair climbing 
and walking together with preventing falls [16, 51, 171]. Weight training with heavy loads 
improves maximal strength, rate of force development and electromyogram amplitude in long 
term immobilised patients in a post surgery setting. Rate of force development correlates with 
walking speed, highlighting the importance of training both the neurological and 
morphological aspects of the muscle [171]. Increasing muscular strength could mean shifting 
the load of daily activity from heavy, to tolerable and repeatable [103]. If supervised training 
result in a more active lifestyle it may increase the outcome of the training above the “dose” of 
exercise prescribed, and may be considerably greater than the effect of directly prescribed 
pharmacotherapy [137].  
1.18 The safety of strength training in coronary artery disease  
Strength training in coronary artery disease patients renders the possibility of an acute increase 
in blood pressure and disturbed ventricular function. Exercise loads between 40% to 60% and 
above 95% of  1RM are considered safe due to small increases in blood pressure [22], however 
both 1RM testing and weight training with heavier loads are well tolerated in coronary artery 
disease patients [103]. Moderate resistance training did not effect the left ventricular function 
in coronary artery disease patients [88], and strength and endurance exercise maintained left 
ventricular function and cardiac volume to the same extent [107]. Elderly subjects increasing 
1RM through weight training reveal attenuated circulatory response at pre training loads, 
highlighting the importance of increasing strength for better circulatory management in daily 
life activities [104]. When evaluating the electrocardiographic evidence of ischemia during 
weight lifting, no symptoms were found at 40, 60, 80 and 100% of voluntary contraction in 
coronary artery disease patients, while ST segment depressions was observed during maximal 
treadmill exercise. The estimated myocardial oxygen supply-to-demand balance appears more 
favorable with maximal repetition weight lifting than with maximal treadmill exercise [48]. 
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1.19 Blood volume  
Elevated blood volume has been reported in endurance trained subjects and physically active 
elderly [86, 168]. Decreased blood volume is associated with aging, sedentary lifestyle and 
found in standard medicated chronic heart failure patients [38, 49, 86]. An increase in blood 
and plasma volume after aerobic exercise training has been found in some studies [118, 183], 
but not in others [26]. 
1.20 Quality of life  
The effect of exercise training on quality of life has been studied in heart patients with a wide 
variety in instruments, patient selection and training interventions [177]. Training improves 
scores for quality of life significantly, in a clinically meaningful manner [177], and the 
improvement is in parallel to the improvement in VO2peak [19]. Quality of life improve after 
short term training interventions [177, 193] while longer training interventions also report 
improvements in the New York Heart Association functional class score as well [46, 63]. 
Training improving quality of life is also associated with improved self reported disability in 
heart failure patients [190]. 
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2 Objective  
In the present thesis the main focus was to explore new and improved aspects of endurance 
and strength training for coronary artery disease patients, with the aim of better clinical 
practise in the future. In addition we sought to investigate the effect of different aerobic 
training intensities matched for energy expenditure on healthy subjects.  
 
The aims of the studies were to:  
 
1. Compare the effects of aerobic endurance training of different methods and intensities 
matched for total work and frequency.  
2. Determine to what extent high aerobic intensity interval training affects peak stroke 
volume and myocardial contractility and function in coronary artery disease patients.   
3. Further develop high aerobic intensity interval training for coronary artery disease 
patients focusing on limitations to endurance training through studying the response to 
hyperoxic high aerobic intensity interval training.   
4. Determine how maximal leg press training with maximal mobilisation, few repetitions 
and high load effects muscular strength, rate of force development and walking 
mechanical efficiency in coronary artery disease patients. 
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3 Methodology  
3.1 Oxygen uptake 
3.1.1 Walking efficiency  
Submaximal oxygen uptake was measured at a work load corresponding to 40 watt 
during treadmill walking (Technogym runrace, Italy) before and after training in study 
IV. To define the walking speed corresponding to 40 watts on the treadmill we used the 
following equation: 
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Oxygen uptake was determined through 5 minutes of continuous respiratory 
measurements (V-max spectra, SensorMedics, USA), and the mean oxygen uptake 
measured during the last minute of walking was used to calculate the net efficiency 
through the following equation:  
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Resting energy expenditure was set to 3.5 ml. kg-1. min-1. Both oxygen uptake and watts 
were converted to kilojoules to allow for calculation of percent mechanical efficiency 
[78].  
3.1.2 Running economy  
In study I running economy was determined before and after the training intervention with 
subjects running 4 minutes at the standardised work load 7 km . h-1 and 5.3% inclination 
(Technogym runrace, Italy). Continuous respiratory measurements were performed and the 
mean oxygen uptake values from the last minute were used to determine running economy 
(Cortex Biophysik GmbH, Leipzig, Germany).    
3.1.3 Maximal/Peak oxygen uptake 
VO2peak was determined after the submaximal test in study II-IV by increasing the work 
load until subjects reached exhaustion. Continuous respiratory measurements was 
carried out, and the mean of the three highest 10 seconds continuous breath by breath 
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respiratory measurements determined VO2peak (V-max spectra, SensorMedics, USA). 
Walking speed was kept constant while the treadmill inclination was increased 1-3% 
every minute until VO2peak was reached. The criteria for VO2peak were an R value above 
1.0 and a Borg scale value above 15. Heart rate was recorded (Polar sports tester, 
Finland) and non-haemolysed capillary blood was collected for lactate measurement 
after the test (YSI Incorporated, USA). Subjects reported perceived exhaustion at peak 
exercise using the Borg scale.  
 
In study number I subjects continued to run on the treadmill after work economy and lactate 
threshold measurements was complete (Technogym runrace, Italy). Subjects ran at 5.3 % 
inclination and the running speed was increased every minute until VO2max was reached 
during 3 to 6 minutes. The test principles followed established standards for testing of aerobic 
power in humans [200], and the automated respiratory methods using the Metamax II portable 
metabolic test system and breath by breath measurements to determine VO2max (Cortex 
Biophysik GmbH, Leipzig, Germany). The average of the three highest continuous 10 
seconds measurements were used to determine VO2max.  
 
 
Figure 1. Testing of oxygen uptake 
 
3.2 Cardiac output and stroke volume 
Cardiac output was measured through study I-IV using the single breath gas technique to the 
Sensormedics Vmax Spectra 229 (SensorMedics Corp, California, USA). The test were 
initiated with a 10 minute warm up period on the treadmill followed by gradually increasing 
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work load until cardiac output were measured at 80-85% of VO2peak in study II-IV and at 
speed corresponding to VO2max in study I. When subjects reached the correct intensity they 
were instructed to start a breathing cycle with a complete emptying of the lungs followed by 
maximal inspiration of a gaseous mixture of 0.3% carbon monoxide, 0.3% acetylene, 0.3% 
methane, 20.9% oxygen balanced with 78.2% nitrogen, directly followed by one continuous 
expiration. In the solution acetylene serves as the soluble gas and methane the insoluble. The 
test method has previously been validated against the indirect Fick carbon dioxide rebreathing 
method and compared with open-circuit acetylene uptake, and found reliable and valid for 
measuring cardiac output. A coefficient of variation of 7.6% was found at a work load of 
200W and the authors concluded that the single breath measurements requires a constant, 
slow exhalation rate making the procedure difficult to perform at the highest intensities [39].  
 
 
Figur 2. Testing of peak stroke volume  
3.3 Total blood- and plasma volume 
The long slow distance and 4 x 4 minute interval training group in study number I, and the 
hyperoxic training group in study number III had the blood- and plasma volume determined 
through the Evans blue dye dilution technique before and after training [122]. Subjects rested 
30 minute in a supine position before a venous catheter was inserted in the antecubital vein in 
the upper arm. A 6 ml venous blood sample was drawn, before approximately 2.5 ml of Evans 
blue dye was injected into the vein. A 3 ml blood sample was drawn into a sodium heparine 
vacutainer tube at 10, 20 and 30 minutes after the Evans blue dye injection to evaluate the 
 23
dilution of dye in the blood. After collection the vacutainer tubes were spun in an 
ultracentrifuge for 10 minutes at 3500 revolutions . min-1 (Kubota 2010, Japan). Plasma was 
transferred to a blank container and samples read in a spectrophotometer (Shimadzu UV-
1601, Japan) at wavelengths 620 and 740 nm. Hematocrit was measured using a Cobas 
Micros CT16 (Bergman Instrumentering as, Norway), and blood volume estimated by 
dividing plasma volume by one minus hematocrit. Corrections for trapped plasma and 
peripheral sampling were performed [122]. 
 
 
Figure 3. Testing of blood volume 
3.4 Cardiovascular magnetic resonance  
All patients in the endurance training group in study II underwent CMR examination before 
and after the training period using a Philips Intera® 1.5 T MR whole body scanner (Phillips, 
Best, Netherlands), equipped with a 5-element cardiac phased array coil and cardiac software 
package (R9.1.1). Breath-hold cine two-chamber, four-chamber and long-axis views were 
acquired using a retrospectively electrocardiographically gate steady state free procession 
(SSFP) breath-hold cine sequence. A stack of 10-mm thick contiguous slices encompassing 
the left ventricle from base to apex in the cardiac short-axis orientation was acquired for 
volumetric measurements. Imaging parameters included the following: 2.9/1.4 (repetition 
time ms/echo-time ms), 160 × 160 matrix, 320 × 320 mm field of view, 2.0 × 2.0 mm in-plane 
spatial resolution, half Fourier acquisition and 65-degree flip angle. A total of 30 heart phases 
were acquired. End diastolic volume (EDV), end systolic volume (ESV), left ventricular mass 
(LVM), stroke volume (SV), cardiac output (CO) and ejection fraction (EF) were measured 
by semiautomated segmentation of end-diastolic and end-systolic areas using dedicated 
software (Easyvision, Philips, Best, Netherlands) [91, 169]. Cardiac magnetic resonance stress 
testing allows for assessments of morphology and cardiac function and is a diagnostic tool for 
 24
coronary artery disease [32, 34]. The main concern with the use of cardiac magnetic 
resonance imaging is the motion of coronary arteries in the respiratory and cardiac cycle 
[165], however techniques for free breathing and correction through contrast agents and 
navigator techniques has been developed [169].  
 
 
Figure 4. Magnetic resonance imaging   
3.5 Maximal skeletal muscle strength  
Maximal strength in the lower extremities was tested by 1RM in a dynamic horizontal leg 
press down to a knee joint angle of 90° using a horizontal leg press machine (Technogym, 
Italy) in study number IV. 1RM was obtained by repeating the leg press exercise with 
increasing loads of 5-10 kilogram until the subjects were not able to complete the lift. A total 
of 6-8 lifts were used to achieve 1RM and the highest weight lifted was recorded as 1RM. 
3.6 Rate of force development 
Maximal voluntary rate of force development and peak force during 90° dynamic leg 
press movement were assessed through a force platform (9286AA, Kistler, Switzerland) 
installed on the leg press machine (Technogym, Italy) in study number IV. Subjects 
performed 2 sets of dynamic leg press focusing on maximal force production with a 
resistance of 40 kilogram (kg). Data was collected at 2000 Hz (Bioware v3.06b, Kistler, 
Switzerland) and rate of force development was measured between 10-90% of peak 
force in the concentric phase of the leg press.  
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Figure 5. Testing of 1RM and rate of force development  
3.7 Training Intervention 
3.7.1 Interval training  
Coronary artery disease patients in study II and III performed high aerobic intensity interval 
training through treadmill walking in a total of 30 interval training sessions. After 10 minutes 
of warm up, patients performed 4 x 4 minutes of aerobic intervals at 85-95% of the individual 
patients peak heart rate, corresponding to 80-90% of VO2peak. 3 minutes active brakes were 
used in-between the high intensity periods at intensities corresponding to 65-75% of peak 
heart rate. Inclined treadmill walking were chosen due to 10-20% better performance during 
uphill walking and running compared to stationary biking [111], allowing for close control 
over intensity, patients well being and safety during training. Training intensity was chosen 
after documentation of the superiority of high aerobic intensity interval training compared 
with moderate intensity for increasing VO2peak in coronary artery disease patients [153]. Heart 
rate was used as a control of training intensity, and the training load was increased whenever 
the heart rate was not maintained at the desired level during intervals. All training sessions 
were supervised to ensure training quality and patient safety, and no adverse events were 
reported during the studies. Individual training data such as walking speed, treadmill 
inclination, heart rate and Borg scale for perceived exhaustion was recorded in a training log, 
and the compliance of training was 29.6 ± 0.7 and 29.1 ± 1.1 training sessions in study II and 
III respectively.  
 
Four different endurance training interventions were performed in study number I. All 
training sessions were performed running at a treadmill of 5.3% inclination. Training 
interventions 2-4 started with a 10 min warm up and ended with a 3 min warm down period at 
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70% of maximal heart rate. Subjects carried out three training sessions per week for eight 
weeks, a total of 24 sessions. The four training interventions included:  
1. Low slow distance running (LSD): The first group performed a continuous run at 70% 
of maximal heart rate for 45 min 
2. Lactate threshold running (LT): The second group performed a continuous run at 
lactate threshold at 85% of maximal heart rate for 24.25 minutes. 
3. 15 x 15 seconds interval running (15x15s): The third group performed 47 repetitions 
of 15 s intervals at 90 to 95% of maximal heart rate with 15 seconds active resting-
periods at warm up velocity, corresponding to 70% maximal heart rate between each 
interval.  
4. 4 x 4 minute interval running (4x4 min): A fourth group trained 4 x 4 minutes interval 
training at 90-95% of maximal heart rate with 3 minutes active resting-periods at 70% 
of maximal heart rate between each interval.  
 
Each training intervention was made equal in terms of energy consumption after an accurate 
calculation and a pilot study where active periods and warm up was included. On average the 
total oxygen uptake for the training protocols was 130 ± 15 Litre or approximately 650 Kcal 
per training session.  
 
 
Figure 6. Hyperoxic high aerobic intensity interval training  
3.7.2 Strength training  
Coronary artery disease patients trained maximal strength training of the legs in study number 
IV. Patients met to training at the exercise physiology laboratory three times a week for 8 
weeks completing a total of 24 strength training sessions. Each strength training session 
consisted of 5 minutes warm up of stationary biking and 4 series with 4 repetitions in each 
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series of horizontal dynamic leg press. Exercise was made with emphasis on maximal 
mobilization of force in the concentric action and subjects started the concentric movement 
when the knee angle corresponded to 90°. Subjects trained with a progressive work load of 
85-90% of the individual 1RM. When subjects were able to perform more than four 
repetitions in a set, the load was increased by 2.5 kg. A 2 minutes rest period was employed 
between each set of exercise. The compliance of training was 23.8 ± 0.4 training sessions.  
3.8 Statistical analysis  
Statistical analyses were performed using the software program SPSS, version 11.0-14.0 
(Statistical Package for Social Science, Chicago, USA). Table values are expressed as mean ± 
standard deviation (SD), while figure values are expressed as mean percentage change and 
data variability as standard error (SE). A two-tailed p < 0.05 was accepted as statistically 
significant for all tests. Q-Q plots were used to test data for normal distribution. Due to the 
relatively small sample size non parametric statistics tests were chosen in paper II-IV. 
Changes within groups were determined by the Wilcoxon signed ranks test, while differences 
between groups were calculated by using the Mann-Whitney U-test on delta changes from pre 
to post test. Relationships between variables were assessed with correlation analysis. In paper 
number I differences within and between groups was calculated through a two-way analysis 
of repeated measures ANOVA (least significance difference test) comparing means for 
continuous variables.  
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4 Summary of Results  
Paper I. Aerobic High-Intensity Intervals Improve VO2max More Than Moderate Training 
   
The objectives of this study was to compare the effects of aerobic endurance training at  
different intensities- and methods matched for total work and frequency.  
1. VO2max increased by 5.5% in the 15/15 and by 7.2 % in the 4x4 group after training, 
with no difference in the training response between the 15/15 and 4x4 group. 
2. No change in VO2max was detected in the LT and LSD group. 
3. Running economy significantly improved in all the training groups by 7.5-11.7%, but 
no difference was detected between groups.  
4. Lactate threshold did not change in any of the groups when expressed as % VO2max. 
Velocity at lactate threshold was however significantly improved by an average of 
9.6% in all four groups as a consequence of change in running economy and VO2max.    
5. Stroke volume changed from pre to post training in the 15/15 and the 4x4 min group. 
No significant difference was observed between the two groups, however the smallest 
p value was detected in the 4 x 4 min group.  
6. No significant haematological response to training was found. 
 
Paper II. How to Improve Stroke Volume in Heart Patients 
 
The objectives of this study was to investigate to which extent aerobic interval training at 85- 
95% of maximal heart rate improves peak stroke volume and myocardial ejection fraction in 
coronary artery disease patients. 
1. Peak stroke volume significantly improved by 23% after interval training. 
2. Resting left ventricle ejection fraction significantly improved by 5% after interval 
training.  
3. Resting left ventricle end diastolic volume and myocardial weight as well as cardiac 
output was unchanged after training. There was a non-significant trend towards 
decreased end systolic volume and heart rate, as well as increased stroke volume.   
4. VO2peak significantly improved by 17% after high aerobic intensity interval training 
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Paper III. Aerobic interval training improve VO2peak in heart patients; no additional effect 
from hyperoxia 
 
The objectives of this study were to investigate if 100% oxygen supplementation during high 
aerobic intensity interval training improves training performance and VO2peak in coronary 
artery disease patients.  
1. VO2peak improved 16% and 17% after 30 training session of high aerobic intensity 
interval training at 85-95% of peak heart rate in the hyperoxic- and normoxic training 
group respectively. 
2. VO2peak improved 0.53 and 0.57% per training session in the two training groups  
3. VO2peak was equal in hyperoxia (65% O2) and normoxia (21% O2) in the hyperoxic 
training group both before and after interval training.  
4. Peak stroke volume increased significantly after high aerobic intensity interval 
training in both training groups.   
5. Blood volume did not change after 10 weeks of hyperoxic interval training in the 
hyperoxic training group.   
6. Quality of life improved in both training groups after interval training.  
 
 
Paper IV. Strength Training Restores Walking in Heart Patients 
 
The objectives of this study were to investigate the effect of maximal strength training of the  
legs has upon leg strength, rate of force development and walking mechanical efficiency in 
coronary artery disease patients.  
1. Maximal strength in leg press measured through one repetition maximum increased by 
44% after strength training.    
2. This corresponds to an increase in strength by 1.6% per training session.  
3. Maximal strength training increased rate of force development by 85%. 
4. Maximal strength training increased peak force by 18%. 
5. Maximal strength training increased walking efficiency by 35%.  
6. Quality of life increased significant in the score for mental health after strength 
training. 
7. Maximal strength training did not change total serum testosterone.  
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5 Discussion  
The present thesis reports that high aerobic intensity training at 90-95% of maximal heart rate 
improves VO2max and maximal cardiac stroke volume in healthy young men, whereas 
isocaloric training protocols at lower intensities does not result in any changes (I). High 
aerobic intensity interval training at 85-95% of peak heart rate improves VO2peak and peak 
cardiac stroke volume in coronary artery disease patients to the same extent as healthy young 
men (II-III). Hyperoxic high aerobic intensity interval training gives no additional 
improvements in VO2peak or peak cardiac stroke volume compared with normoxic training in 
coronary artery disease patients. Patients were oxygen demand limited in the skeletal muscles 
at VO2peak during acute hyperoxic testing both before and after training (III). Maximal 
strength training of the legs enhances muscular strength and walking efficiency in coronary 
artery disease patients despite no change in VO2peak (IV).  
5.1 Improvements in maximal aerobic power  
The present thesis confirms that the intensity of endurance training is the most important 
factor to improve maximal oxygen uptake (VO2max) in healthy young men (I). This is also in 
line with previous studies in cardiovascular disease patients [153, 193]. The present thesis 
demonstrates and confirms that VO2max, VO2peak and performance increase significantly with 
high aerobic intensity interval training at 85-95% of peak heart rate. The increase in aerobic 
power is achieved after a few weeks of training, in both healthy men and coronary heart 
disease patients (I-III). In healthy young men only training intensities at 90-95% of maximal 
heart rate, performed after interval principles improved VO2max (I). This differs from previous 
studies of coronary heart disease and heart failure patients, where long slow distance training 
at 70% of peak heart rate improved VO2peak as well. The improvement in VO2peak was 
however only half of the outcome from high aerobic intensity interval training [153, 193]. The 
VO2max was higher in the healthy young men (I) compared with previous studies of 
cardiovascular disease patients [153, 193]. The mean VO2max was between 55 and 60 ml . kg-1 . 
min-1 in study number I, while mean VO2peak ranged from ~13 ml . kg-1 . min-1 [193] to ~31 ml . 
kg-1 . min-1 [153] in previous studies of heart patients. The results may imply that low intensity 
endurance training may increase VO2max when VO2max is initially low. When choosing mode 
and intensity of endurance training the amount of improvement desired per training session, 
and the initial level of aerobic power might be considered before expectations of 
improvements are set.  
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High aerobic intensity interval training improves VO2peak in coronary artery disease patients to 
a greater extent than VO2max in healthy young men when expressed as percent improvement 
(I-III). VO2peak increased by an average of 0.53-0.57% per training session in coronary artery 
disease patients. Half the improvement in VO2max per training session was observed in healthy 
young men with an average of 0.23-0.30 % increase in VO2max. The relative difference is due 
to the lower initial aerobic power observed in coronary artery disease patients. When 
comparing the absolute change in aerobic power surprisingly similar results are observed 
between studies. On average coronary artery disease patients improved VO2peak by 4 ml . kg-1 . 
min-1 and 4.5 ml . kg-1 . min-1 in study II and III, respectively. In study number I, high aerobic 
intensity interval training by 15 x 15 seconds and 4 x 4 minutes improved VO2max on average 
3.9 ml . kg-1 . min-1 and 4.9 ml . kg-1 . min-1, respectively. Converted to improvement per training 
session, 0.13 ml . kg-1 . min-1, 0.15 ml . kg-1 . min-1, 0.16 ml . kg-1 . min-1 and 0.20 ml . kg-1 . min-1 
was detected in study II, III and group 15x15 second and 4 x 4 minutes in study I, 
respectively. This implies that coronary artery disease patients through supervised training 
can perform high aerobic intensity interval training with equal quality as healthy young male 
subjects. So, despite documented coronary artery disease and myocardial insufficiency 
coronary artery disease patients achieve similar training outcomes as healthy young men 
when expressed as absolute values. The similarity in the training outcome between studies 
serves as an indication of the potential high intensity interval training possesses as long as it is 
performed aerobically. The equality in the training response might serve as an argument for 
incorporating high aerobic intensity interval training as part of recommendations for 
cardiovascular disease patients.  
 
When considering the importance of high VO2peak in association with mortality in 
cardiovascular disease patients [117] it should be noticed that high aerobic intensity interval 
training rapidly increases VO2peak in a high mortality risk population. The mean increase in 
VO2peak was approximately 4 – 4.5 ml . kg-1 . min-1 after 30 interval training sessions in 
coronary artery disease patients (II-III). According to Myers et al. [117] a 1 MET (3.5 ml . kg-1 
. min-1) increase in aerobic power corresponds with a 12 % reduction in mortality risk. High 
aerobic intensity training thereby serves as a non pharmaceutical treatment, substantially 
reducing the risk of mortality in only a few weeks. In addition training might serve as a 
protective agent against further development of coronary artery disease [176], and improve 
risk factors related to cardiovascular disease [14, 175]. A large improvement in VO2peak 
inflicted by high aerobic intensity interval training in a short period of time is both significant 
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and clinically meaningful for the patients. Training might appear motivational since patients 
quickly sense the effect of training in their daily life.  
 
Current guidelines regarding training and health recommends 30 minutes of not necessarily 
structured, moderate exercise, preferably every day of the week to ensure health benefits 
[175]. The recommendation might be questioned in view of the result from the present thesis, 
and the importance of high aerobic power for reducing mortality [57, 113, 117]. One might 
argue that some elements of high aerobic intensity training are needed to ensure good health 
in both healthy subjects and coronary artery disease patients. This might be particular 
important in coronary artery disease patients with low initial VO2peak, where significant 
improvements in fitness and risk of mortality might be obtained in just a few weeks of 
training (II-III). If a relationship exist between cardiovascular fitness and health aspects the 
fact that high aerobic intensity training improves VO2max in healthy subjects is important to 
consider. According to the data from the present study (I), a young and healthy population 
would probably not experience any improvements in VO2max following the recommendations 
from the present guidelines and training or activity would merely serve as a means of 
maintenance. High aerobic intensity training is reported to be twice as effective as low 
intensity training in improving VO2peak in heart patients [153, 193]. In this population 
cardiovascular fitness has been proven vital for future development of the disease and life 
expectancy [58, 85]. With the important link between cardiovascular fitness and mortality risk 
high aerobic intensity interval training has the ability to quickly increase cardiopulmonary 
fitness and thereby health prospects as well. 
 
Maximal strength training of the legs did not enhance VO2peak in coronary artery disease 
patients (IV), however, as expected the work efficiency was improved. VO2max is minimally 
effected by maximal strength training [94], however enhanced muscular strength may 
stimulate to increased voluntary endurance activity. With a limited VO2peak in coronary artery 
disease patients, improvements in walking efficiency directly translate into similarly 
improved walking ability and performance.  
5.2 Myocardial changes with training 
In the present thesis high aerobic intensity interval training significantly improved peak stroke 
volume in both coronary artery disease patients and healthy young males (I-III). Peak stroke 
volume was initially higher in healthy young men compared with coronary artery disease 
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patients with mean values between ~130 and 155 ml . beat-1 in healthy young men and ~90 and 
114 ml . beat-1 in coronary artery disease patients before training. Peak stroke volume 
improved relatively the most after training in coronary artery disease patients with ~ 15-17 % 
improvement (II-III) while healthy young men improved stroke volume by ~10% (I). The 
slightly larger percent increase in stroke volume observed in coronary artery disease patients 
after training compared to healthy young men, matches the larger percent improvement in 
aerobic power noted in coronary artery disease patients compared with healthy young men. 
The absolute delta values are however, as observed with VO2peak and VO2max, surprisingly 
equal between studies. Maximal stroke volume improve with ~14-15 ml . beat-1 and peak 
stroke volume by ~15-21 ml. beat-1 in healthy young men (I) and coronary artery disease 
patients (II-III), respectively. The improvement per interval training session was 0.58-0.63 ml 
. beat-1 and 0.51-0.70 ml . beat-1 in the healthy young men (I) and coronary artery disease 
patients, respectively (II-III). This implies that despite reduced initial stroke volume, reduced 
myocardial efficiency and documented ischemic heart disease, coronary artery disease 
patients have the same absolute myocardial response to high aerobic intensity interval training 
as healthy young men. High aerobic intensity interval training thereby seems to inflict the 
same shear stress on the cardiovascular system improving the oxygen supply to working 
skeletal muscles in both young healthy men and coronary artery disease patients. Stroke 
volume deterioration documented with aging and disease may thereby primary reflect 
increasing levels of inactivity, at least before ischemia and infarction may disrupt peak 
myocardial function. 
 
High aerobic intensity interval training improved resting left ventricle ejection fraction in 
coronary artery disease patients (II). Improvements in peak stroke volume in coronary artery 
disease patients is probably due to increased myocardial contractility as observed with 
increased resting left ventricular ejection fraction. Improvements in resting left ventricular 
ejection fraction has previously been reported in old heart failure patients together with a 
reversal of left ventricle remodelling [193]. High aerobic intensity interval training did not 
change the left ventricle dimension, indicating that a larger dose of high aerobic intensity 
interval training might be needed to achieve the reported increase in left ventricle dimension 
observed in endurance trained female athletes [192]. In the present study (II), there was a 
trend toward decreased end systolic volume with a subsequent increase in stroke volume. 
Heart rate decreased correspondingly, maintaining an unchanged cardiac output. All those 
changes are concordant, indicating that the trend is real. In addition, the result was a 
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significant increase in resting ejection fraction, indicating an enhanced left ventricular systolic 
performance. Left ventricle ejection fraction and reversed myocardial remodelling 
normalizing myocardial size has been reported to be dependent of training intensity, with only 
aerobic interval training demonstrating changes in heart failure patients [193]. 
 
Training intensities below 85% of maximal heart rate did not improve maximal stroke volume 
or VO2max in healthy young men (I). The present thesis thereby reports a dependency of 
training intensity in the effort to improve maximal stroke volume in healthy individuals. The 
effect of long slow distance training on peak stroke volume was not investigated in coronary 
artery disease patients in the present studies (II-III). Based on the similarities in the response 
in VO2peak and peak stroke volume detected in healthy men and coronary artery disease 
patients, a logic deduction might be expecting peak stroke volume to follow the improvement 
in VO2peak reported in the study by Rognmo et al. [153]. The effect of long slow distance 
training in their study was half that of high aerobic intensity training in coronary artery 
disease patients. The fact that stroke volume plateaus at different level of maximal heart rate 
[54, 196] may explain why high aerobic intensity training is needed to improve VO2max and 
maximal stroke volume in healthy young men. When training at 90-95% of maximal heart 
rate the healthy young men train at the highest cardiac output they can maintain over 3-8 
minutes influencing the cardiovascular system maximally. Training at a lower intensity may 
not inflict enough shear stress on the cardiovascular system due to training at a lower cardiac 
output. According to the data from Zhou et al. [196] and Gledhill et al. [54] cardiac patients 
with low initial VO2peak reach peak cardiac output at a low percentage of maximal heart rate, 
thereby low intensity training may also increase peak stroke volume and VO2peak in these 
patients as well [153].  
 
The present thesis displays a differentiation in stroke volume response with endurance 
training intensity. Maximal or peak stroke volume in moderately trained healthy young men 
and coronary artery disease patients improve to a similar extent after high aerobic intensity 
interval training. This highlights the importance of training intensity in healthy subjects and 
particularly in coronary artery disease patients with already reduced myocardial function. The 
improvement in stroke volume seems to follow the changes in aerobic power in both healthy 
men and coronary artery disease patients. This indicates that myocardial function and skeletal 
muscle metabolism are closely matched and that training responses at the supply and demand 
level go hand in hand.  
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Maximal strength training with high load and focus upon maximal voluntary contraction does 
not change stroke volume or cardiac output in coronary artery disease patients (IV), therefore 
intensity dependent endurance training must be applied to achieve improvements in 
myocardial function. Strength training may however serve as an important means for better 
circulatory management and blood pressure control in coronary artery disease patients [104]. 
The present studies together with others [193] suggest that that coronary artery disease 
patients following the traditional part of official guidelines will not experience optimal 
coronary adaptations from training on a dysfunctional myocardium [193].   
5.3 Demand and supply limitations to training   
High aerobic intensity interval training increases the oxygen delivery to working skeletal 
muscles through elevated peak stroke volume in both healthy individuals and coronary artery 
disease patients (I-III). Peak stroke volume is elevated to the same extent as VO2max or VO2peak 
implying that the oxygen demand is at least on level with the supply of oxygen, but might be 
higher.  
 
In coronary artery disease patients no acute effect of hyperoxia was found on VO2peak and 
performance, despite significantly increased haemoglobin oxygen saturation. This observation 
indicates a demand limitation to oxygen consumption in the working skeletal muscles of the 
coronary artery disease patients at the inclusion point in the study (III). Oxygen supply often 
limits VO2max in the healthy human skeletal muscles [92, 147-149, 157, 181], however 
metabolic limitations in VO2max is suggested in unfit subjects [182]. Depressed oxidative 
capacity in the skeletal muscles of heart failure patients has been reported, implying that 
VO2peak is limited by the oxidative capacity of mitochondria in the working muscles [41]. This 
is in agreement with the findings in the present study of coronary artery disease patients 
where 65% inspired oxygen had no effect on VO2peak and performance. Some studies report 
increased VO2peak and performance in coronary artery disease patients exposed to hyperoxia, 
while others do not observe changes in VO2peak in line with the observations in paper number 
III [146, 154]. As discussed in the paper (III) several other factors not controlled for in the 
study, as vascular vasoconstriction restricting oxygen supply to the working skeletal muscles, 
or the level of myocardial ischemia affecting myocardial contractility may also have 
contributed to the lack of improvement in exercise performance. In addition it is important to 
note that the coronary artery disease patients did not suffer from exercise induced hypoxemia 
during peak normoxic exercise, thereby oxygen delivery was not initially limited in normoxia. 
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Endurance trained healthy men were not investigated during hyperoxic exposure thereby no 
conclusions may be drawn in that context. 
 
Hyperoxic high aerobic intensity interval training gave no additional effect on performance 
outcome compared with normoxic training. The present study (III) report that 30 hyperoxic 
high aerobic intensity interval training sessions increases VO2peak and peak stroke volume to 
the same extent as normoxic training. This implies that under both training environments 
there is an equal oxygen supplementation and use of oxygen in the energy converting process 
in the working skeletal muscles. Thereby an equal training load was performed during both 
hyperoxic and normoxic training, and no additional shear stress was initiated to the 
cardiovascular system during hyperoxic training. The result is an equal high peak stroke 
volume and VO2peak response between the two training groups. 
 
Further investigations may reveal if hyperoxia is beneficial in severely ischemic coronary 
artery disease patients with ischemic coronary contractile restrictions. The present study (III) 
demonstrates that a VO2peak below 35 ml . kg-1 . min-1 is associated with a metabolic skeletal 
muscle demand limitation in coronary artery disease patients. VO2peak above this level might 
be needed before the limitations to exercise is switched from oxygen demand towards oxygen 
supply limitations. The present data (III) is in line with other studies were hyperoxic 
endurance training is reported to have no additional effect on VO2max, even with higher 
VO2max values reported in the subjects participating [134, 140]. The practical implication from 
the present study (III) is that mildly ischemic coronary artery disease patients does not benefit 
from hyperoxic supplementation during training and that thirty high aerobic intensity interval 
training sessions did not seem to be enough to switch from oxygen demand to oxygen supply 
limitation to exercise, thereby aerobic interval training can safely be performed in normoxia 
with equally high performance outcome.  
5.4 Maximal strength training  
Maximal strength training focusing on heavy loads, maximal voluntary contraction and few 
repetitions improves muscle strength and muscular contractility in coronary artery disease 
patients (IV), in line with other patient groups [75] and healthy subjects [72, 74]. Maximal 
strength training was well managed by the coronary artery disease patients and no adverse 
events were reported during strength training (IV). Improved muscle strength is important in 
many contexts, one being the occurrence of muscle atrophy and muscle weakness in coronary 
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patients [180], another muscular strength as a predictor of survival and the aggravation of 
muscle metabolism and skeletal muscle function with progressing New York Heart 
Association grading [10, 79, 189]. Thirdly low muscle strength is associated with high levels 
of disability in heart disease patients, reporting higher levels of disability than healthy age 
matched individuals [138], together with the loss of independence [40]. Low skeletal 
muscular strength and exercise impairment is reported to be due to skeletal muscular defects 
rather than limitations from the heart disease itself [109]. The advantage of maximal strength 
training is a rapid increase in skeletal muscular strength without any gain in body weight. 
Increased skeletal muscular strength renders the possibility to reduce disability and move the 
threshold of daily activities further away from 1RM. Another positive effect is enhanced level 
of daily activity, positively affecting cardiopulmonary fitness. Supervised training has the 
potential to reverse the fear of being physical active in this patient group [120]. Increased 
muscular strength is especially important in heart patients since increasing 1RM attenuates the 
circulatory response giving better circulatory management in day to day activities [104].  
 
Maximal strength training increases the rate of force development in coronary artery disease 
patients (III), to the same extent as healthy subjects [72], and COPD patients [75]. The rate of 
force development is important in terms of the ability to rapidly develop force in the skeletal 
muscles, and contribute to better walking, stair climbing and prevents falls [16, 51, 94, 171]. 
Increased skeletal muscle strength through neural adaptations reported as increased rate of 
force development makes large increases in muscle strength feasible without increasing body 
weight, and are together with improved walking performance an indication of the importance 
of training both the neurological and the morphological aspects of the muscle [171]. Increased 
muscular strength could mean shifting the load of daily activity from heavy, to tolerable and 
repeatable [103], and the present study (III) demonstrates that a large increase in muscular 
strength is possible through maximal strength training, without any adverse events, and 
minimal time spent exercising. The importance of maximal strength training is highlighted 
even more through its effect on endurance performance in coronary artery disease patients.  
 
Maximal strength training did not change serum testosterone concentration in coronary artery 
disease patients (IV). The coronary artery disease patients already within the laboratory 
normal range systemic testosterone levels did not change testosterone levels in response to 
training. Low testosterone levels have been reported in connection with cardiovascular 
disease [172], and the use of testosterone supplementation has been discussed in this patient 
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group. In the present thesis training did not affect serum testosterone concentration and 
thereby cannot at the present time be recommended as an alternative to testosterone 
supplementation in cardiovascular disease populations with low testosterone levels.  
5.5 Walking efficiency and running economy  
Maximal strength training affects endurance performance in addition to improving skeletal 
muscular strength and contractility. In coronary artery disease patients submaximal walking 
efficiency is reduced [78], but returns to the level of healthy age matched adults after 8 weeks 
of maximal strength training (IV). Maximal strength training improves walking mechanical 
efficiency considerably by 35% after only 24 training sessions. Strength training as part of 
rehabilitation of coronary artery diseases has the past years received more focus, after periods 
with endurance training primarily receiving attention [22]. This study verifies the importance 
of integrating maximal strength training in a rehabilitation setting since coronary artery 
disease patients gains a substantial strength and endurance outcome through a minimal 
training effort. This might prove very important for coronary artery disease patients whom 
due to the fear of the consequences of the disease often are inactive and thereby develops 
reduced skeletal muscle function and reduced physical capacity [109]. Improvements in 
submaximal endurance performance may stimulate to increased level of voluntary endurance 
activity at a higher intensity and increase the total daily energy expenditure [5], an important 
aspect in further development or regression of coronary artery disease [64]. Also increased 
skeletal muscular strength gives better management of daily living and increase the 
independence of elderly coronary artery disease patients [6]. Increasing the daily activity level 
has the potential to decrease the progression of the cardiovascular disease and improve the 
mortality risk due to increased maximal oxygen uptake [117, 121, 124]. In addition increased 
skeletal muscular strength and endurance performance improves physical function [28], and 
has the potential to better circulatory management in day to day activities [104]. Coronary 
artery disease patients are limited in their ability to walk [78] and report higher levels of 
disability that healthy age matched individuals [138]. Maximal strength training may thereby 
be necessary to imply to increase skeletal muscle strength and physical function [28] before 
patients are able to perform endurance training activities. Strength training has been reported 
to lower risk factors associated with coronary artery disease [15, 81] most likely through 
increased activity levels. Combining maximal strength training and aerobic interval training 
may even produce a larger training outcome of the endurance training due to improved  
submaximal and maximal endurance performance.   
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Improvements in work economy was also detected after long slow distance training, lactate 
threshold, 15 x 15 second and 4 x 4 minutes interval training in healthy young men (I). The 
improvement in work economy was approximately 5% in all groups. Work economy 
improved independent of improvements in VO2max, demonstrating that running economy is 
not affected by the running speed used during training [68, 69]. No significant change in 
lactate threshold was detected in the present study when expressed as percent VO2max however 
the lactate threshold running speed was improved on average by 9.6% in all the groups. 
Improved running speed is to be expected due to increased running economy in all training 
groups.  
5.6 Blood volume  
Blood volume was unchanged after high and low intensity endurance training in healthy 
young men (I), or after hyperoxic high aerobic intensity interval training in coronary artery 
disease patients (III). In study number I, mean blood volume ranged from 5.8 to 6.1 litres, 
while an average of 4.3 litres was measured in coronary artery disease patients in study III. 
Elevated blood volume has been observed in endurance trained individuals and physically 
active elderly [86, 168]. A low blood volume is associated with aging, a sedentary lifestyle 
and is found in medicated chronic heart failure patients [38, 49, 86]. A lower VO2peak, higher 
age and the presence of coronary artery disease separated subjects in study III from study 
number I. Thereby cardiovascular disease, medication, age and inactivity in the 
cardiovascular disease patients compared with healthy young men may explain the initial 
difference in blood volume between studies. In addition two women participating in the 
cardiovascular disease study (III) might lower blood volume in this group compared with just 
male participants in study number I. No change in blood volume was detected as a result of 
endurance training in the present thesis (study I & III), neither after long slow distance 
training or high aerobic intensity interval training (I). Increased blood and plasma volume has 
been found in some studies after aerobic exercise training [118, 183], but not in others [26].  
 
Blood volume may already have been well expanded before training for both the studies (I & 
III), reflecting that normal levels of daily activity may be enough to maintain blood volume. 
In the present investigations no long term data can explain the difference in blood volume 
between the studies, however data might serve as an indication for an age or disease related 
reduction in blood volume in cardiovascular disease patients. The amount of blood volume is 
important for circulatory distribution of oxygen and a reduced blood volume might affect 
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endurance performance negatively. The present training interventions does not improve blood 
volume thereby its effect on circulation and oxygen delivery cannot contribute in the 
explanation of the improvements in VO2max and VO2peak as a result of endurance training. At 
the present time the described training interventions cannot be recommended as a means for 
improving blood volume, although effects from longer periods of training cannot be ruled out.  
 
5.7 Quality of life 
In the studies of coronary artery disease patients aspects of measured quality of life was 
improved both due to high aerobic intensity interval training and maximal strength training. 
The improvement in quality of life is essential due to its clinical importance [177], connection 
with improved coronary functional class score [46, 63] and self reported disability [190]. Both 
improvements in VO2peak (II-III), maximal muscular strength and walking efficiency (IV) 
improves quality of life, implying that several training interventions has the potential to affect 
physical and mental well being and thereby improve daily functionality and abilities.   
5.8 Training is medicine   
The present thesis demonstrates that supervised high aerobic intensity interval training result 
in an equally high training outcome in VO2peak or VO2max in coronary artery disease patients 
and healthy young men, and that training improves the blood supply to the exercising skeletal 
muscles through a larger cardiac stroke volume. Training as treatment of coronary artery 
disease affects further disease development, mortality, reduces the rate of rehospitalisation 
and improve overall heath status [184]. Training has the potential to reduce the cost of 
pharmaceuticals and correct the reduced physical state and function many coronary artery 
disease patients often find themselves in, inspite of modern medical treatment [138, 177, 197]. 
In addition both endurance and maximal strength training may be performed in coronary 
artery disease patients the same way as in healthy individuals without any adverse effects.  
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6 Conclusions  
 
 
High aerobic intensity interval training was more effective than continues training with low to 
moderate intensity in improving maximal oxygen uptake in healthy young men. Maximal 
stroke volume improved due to high aerobic intensity interval training only.  
 
High aerobic intensity interval training at 85-95% of peak heart rate significantly improved 
peak stroke volume and resting left ventricular ejection fraction in coronary artery disease 
patients.  
 
Coronary artery disease patients showed peripheral limitations in peak oxygen uptake both 
before and after 10 weeks of hyperoxic training, thereby hyperoxic training did not improve 
the effect of the training over normoxia.  
 
Maximal leg press exercise focusing on few repetitions with heavy load and maximal 
concentric contractions improved maximal strength, rate of force development, walking 
mechanical efficiency and thus walking performance capacity in coronary artery disease 
patients through a minimal exercise effort.  
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Abstract 
Objectives. To investigate whether hyperoxic aerobic interval training improves training quality 
in coronary artery disease patients. Design. Twenty-one stable coronary artery disease patients 
were recruited to hyperoxic (n=10) and normoxic (n=11) groups (age: 62.4 ± 6.8 years). Patients 
underwent 30 supervised 4x4 minutes interval training sessions using treadmill walking, at 85-
95% of peak heart rate. Results. Arterial saturation was significantly increased by 3% at pretest 
from normoxic to hyperoxic testing conditions. Peak oxygen uptake and stroke volume increased 
significantly by 16% and 17% (p< 0.05) and by 16 % and 18 % (p< 0.05) in the hyperoxic and 
normoxic training groups respectively. No difference was revealed between groups for peak 
oxygen uptake and stroke volume. Blood volumes were unchanged from pre to post training. 
Peak oxygen uptake measured in normoxia and hyperoxia in the hyperoxia training group 
revealed no difference. Conclusion. The present study shows that breathing 100% oxygen 
enriched air during aerobic interval training in stable coronary artery disease patients does not 
improve peak oxygen uptake above the level attained with normoxic training.  
 
 
 
Keywords 
100% oxygen; Endurance training; 4x4 minutes intervals; maximal oxygen uptake; Stroke 
volume 
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Introduction 
Endurance training is an effective means in prevention and rehabilitation of coronary artery 
disease and VO2max identified as the single best predictor of mortality [8]. Our research group has 
previously shown that in short term interventions high intensity aerobic interval training is 
superior to moderate intensity training for increasing aerobic power in coronary artery disease 
(CAD) patients [18]. Reduced stroke volume has been reported at rest and maximal exercise in 
coronary artery disease patients in whom exercise induced myocardial ischemia may reduce the 
myocardial contractile function [20]. Improvements in VO2max after aerobic interval training has 
been linked to improved maximal stroke volume [5]. Increased left ventricular ejection fraction 
and remodeling of the left ventricle associated with increased VO2max have been noted in heart 
failure patients after interval training [24]. A few training studies have investigated the effect of 
hyperoxic training on healthy subjects, showing a 8-9 % increase in exercise load at the same 
heart rate during hyperoxic training, but none have found significant effect on VO2max after 5- 
and 6 weeks of hyperoxic endurance training [11, 13]. These finding are in contrast to the well 
documented increase seen in VO2max and performance during acute inspiration of hyperoxic gas    
[10, 12, 16]. In CAD patients oxygen breathing increased the angina threshold allowing the heart 
to do more work before the development of coronary insufficiency [6], and increased exercise 
performance [6, 7, 14, 17]. Some studies recommend use of oxygen during physical activity, 
especially to patients with anginal pain and ischemic ST depression after exercise. Aerobic 
interval training in hyperoxia may increase the exercise power output from normoxic training 
without raising the already high training heart rate, with the potential of increasing the training 
outcome [11, 13]. Both duration and intensity of the training intervention in hyperoxia are 
crucial. No hyperoxic training study has to our knowledge been performed with CAD patients, 
who may have reduced ability for oxygen delivery to the working muscles through reduced 
myocardial contractility and stroke volume if ischemic [20]. If hyperoxia increases the training 
work load at the normoxic training heart rate, it might increase the training quality, improving 
stroke volume and VO2peak to a greater extent than normoxic exercise. The purpose of this study 
was to investigate whether breathing 100% oxygen enriched air during aerobic interval training 
in cardiovascular disease patients improves the training outcome compared to aerobic interval 
training in normoxic conditions.  
 
 3
   
Methods 
Twenty-one clinically diagnosed stable coronary artery disease (CAD) patients were recruited 
and randomly allocated to a hyperoxic training group (HT) n = 10, and a normoxic training 
group (NT) n = 11 from the St. Olav University Hospital of Trondheim. Physical descriptions of 
patients are shown in table 1. Inclusion criteria were stable CAD, angina pectoris class I-III in 
the Canadian Cardiovascular Society Classification (CCS), ischemia in exercise 
electrocardiogram, or angiographically documented cardiovascular disease. Exclusion criteria 
were unstable angina pectoris, myocardial infarction during the last month, percutaneous 
coronary intervention (PCI) during the last month, left ventricular ejection fraction below 40%, 
complex ventricular arrhythmias, and orthopedic or neurological limitations to exercise. The 
following number of patients used the listed medication; beta-blockers (13), antiplatelet agents 
(15), statins (13), angiotensin-converting-enzyme inhibitors (3), long-acting nitrates (2), and 
diuretics (2). No change in medication was reported during the study.  
 
The study protocol was approved by the regional committee for medical research ethics, and was 
accomplished according to the declaration of Helsinki. Written consent was obtained from the 
subjects. Two patients dropped out of the study while 1 patient was excluded due to repeated 
non- cardiac illness affecting training quality. 
 
Exercise testing were performed pre and post the exercise training period. VO2peak were tested in 
both normoxia (21% oxygen) and hyperoxia (65% oxygen) in the HT in a random order 2 days 
apart while VO2peak were tested in normoxia (21% oxygen) in the NT.  Respiratory testing (V-
max Spectra, SensorMedics, USA) were performed during treadmill walking at 3-5 km per hour 
(Technogym, Italy). The treadmill inclination was raised (1-3%/min) until subjects reached 
exhaustion, and the average of the three continuous highest 10 seconds measurements 
determined VO2peak. Criteria for exhaustion were an RQ value above 1.0 and a Borg scale value 
above 15. RQ was above 1.0 in all patients and Borg scale values above 15 were observed in 14 
patients. In addition, the authors did a subjective evaluation of the level of exhaustion through 
observations of ventilation, walking action and facial expressions in patients at the end stage of 
the test.  
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Heart rate (HR) was measured by a heart rate monitor (Polar Sport, Finland), while arterial 
oxygen saturation (SpO2) was recorded by pulsoximetry in the HT (Critcare Systems INC, 
USA). A capillary blood sample taken immediately after the tests, was analyzed for lactate using 
an YSI 1500 sport tester (YSI Incorporated, USA). Patients self reported exercise exertion 
through the 6-20 Borg scale for ratings of perceived exertion [1].Cardiac output (CO) was 
measured during treadmill walking at 80% of VO2peak through acetylene breathing according to 
the methods previously described by Helgerud et al [5]. During steady state walking patients did 
one complete inspiration and expiration of acetylene gas mixture where inspiration and 
expiration values of gases were used to calculate cardiac output. The test method has previously 
been validated and a coefficient of variation of 7.6% was found [3]. Blood- and plasma volume 
was measured before and after training in the HT using the Evans blue dye dilution technique 
[9], according to procedures previously described [5]. The questionnaires SF36 and Macnew 
were distributed to the patients for measurements of quality of life before and after the training 
periods.  
 
Interval Training  
Patients completed 30 interval sessions with treadmill walking in three weekly sessions during 
10 weeks after the initial testing. Subjects in the hyperoxic and the normoxic training group had 
a compliance of respectively 29.6 ± 0.7 and 29.1 ± 1.1 training sessions. 100% oxygen enriched 
air was distributed to the patients in the HT during exercise. Gas was distributed to the patients 
from a Douglas bag connected to a gas tank, and patient breathed through a face mask and a 
three way valve system. No discomfort was noted due to training with a facial mask, and 
consequently all subjects were able to adhere properly to the training intensity. After 5 minutes 
warm up, patients continued with 4 times 4 minutes of interval training, with 3 minutes active 
breaks in-between each interval. During the 4 minutes intervals patients trained at 85-95% of 
HRpeak, while during active breaks intensity was at 60-70% of HRpeak. To compensate for 
increased VO2peak capacity, treadmill speed and grade were increased several times during the 
study, to make sure the patients trained at 85-95% of their HRpeak at all times. HR and SpO2 were 
recorded during exercise and patients reported self reported exercise stamina through the 6-20 
Borg scale for ratings of perceived exertion [1].  
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All training sessions were supervised by an exercise physiologist. Two subjects in each training 
group experienced angina pain during the start of training sessions early in the study, but were 
able to continue training without having to use nitroglycerine. No other cardiac related incidents 
were reported during the study. 
 
All values are expressed as mean ± standard deviation (SD). Changes within groups were 
determined by the Wilcoxon signed ranks test. Differences between the HT and the NT response 
to training were calculated by using the Mann-Whitney U-test. A two-tailed p < 0.05 was 
accepted as statistically significant for all tests.  
 
With a power of 0.80 and a two sided α value of 0.05 and an expected difference in training 
work load of 8% the calculated number of subjects needed in each group was 7.    
 
Results 
VO2peak, performance, peak ventilation, peak cardiac output and stroke volume increased 
significantly from pre to post training in both training groups (figure 1; table 2; table 3) together 
with scores for physical (10%) and social (9%) quality of life in the HT, and total (9%), physical 
(13%) and social score (10%) in the NT measured by the Macnew questionnaire. No difference 
was found between groups in the improvement in VO2peak, performance, peak cardiac output and 
stroke volume from pre to post the training intervention. Peak oxygen saturation was 
significantly increased by 3% (p < 0.05) from normoxic to hyperoxic testing in the HT (table 2; 
table 4). VO2peak and performance in the HT was equal in hyperoxic and normoxic testing both 
before and after training (table 2; table 4). Peak heart rate and lactate increased significantly from 
pre to post training in the HT, and the HT had a significantly greater increase in peak ventilation 
than the NT, while the opposite were true for perceived exertion through the Borg scale (table 2). 
All other measures, including total blood volume were not significantly different (table 5).  
 
The Borg rate of perceived exertion after each training session was 16.3 ± 0.7 for the HT, and 
14.4 ± 1 for the NT. One patient in the HT showed an elevated  exercise ST segment after the 
training period and was referred for further examination at the cardiac unit at the University 
hospital.  
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Discussion 
The most important finding in this experiment was that stable coronary artery disease patients 
breathing 100% oxygen enriched air during interval training did not show a superior training 
effect over patients training in normoxic conditions. Although arterial oxygen saturation was 
significantly improved in the hyperoxic pretest compared to the normoxic pretest in the 
hyperoxic training group, hyperoxic training showed no additional effect on peak VO2, 
performance, cardiac output or stroke volume compared to normoxic training. In addition no 
acute effect of hyperoxia was detected on VO2peak in the hyperoxic training group before or after 
the training period.  
 
Hyperoxic breathing in cardiovascular disease patients may improve oxygen delivery to the 
myocardium and the skeletal muscles. The use of hyperoxic gas has been found to restore 
electrocardiographic abnormalities in cardiovascular disease patients [14], and may protect the 
myocardium from the hypoxic effect of exercise and increase the angina threshold [6]. The 
negative effect of ischemia with reduced myocardial contractility and stroke volume during high 
intensity training may thereby be prevented. In the present study, a 3% increase in arterial 
oxygen saturation may not be sufficient to overcome a potential ischemic exercise restriction 
during interval exercise, or an oxygen desaturation of 95% may not have been low enough to 
cause myocardial insufficiencies in normoxia effecting aerobic performance. A significant 
increase in SpO2 from 95% to 98% has been reported to be sufficient to increase exercise 
performance in chronic heart failure patients [7], so our patients may be at borderline in terms of 
getting effect from oxygen supplementation on hemoglobin oxygen saturation and training load. 
In addition the present study may not have succeeded in recruiting a severe enough ischemic 
patient population to gain effect from increased myocardial oxygen delivery. Due to treatment 
options like PCI and coronary bypass surgery fewer severe angina patients seems to be available 
as volunteers, and the level of angina might be milder. Hyperoxic supplementation permits the 
ischemic heart to carry out more work before coronary insufficiency develop [6] and may 
therefore be effective in a severe ischemic patient group with greater limitation in cardiovascular 
function during peak exercise.  
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A great number of studies have found VO2max and performance increased in acute hyperoxia, 
alongside an increased hemoglobin oxygen saturation and arterial oxygen content [6, 10, 12, 14, 
16, 17], however all data do not point in the same direction in terms of heart patients. When 
studying the acute effect of hyperoxia in coronary artery disease patients, some investigations did 
not detect improvements in VO2peak and performance. In one investigation, haemoglobin oxygen 
saturation was not increased in hyperoxia compared to normoxia, however, a trend of reduction 
in leg blood flow was detected implying that hyperoxia did not improve muscle oxygen delivery, 
thereby explaining the lack of effect on leg oxygen uptake and performance [19]. In another 
study of heart failure patients haemoglobin oxygen saturation was increased in hyperoxia 
however no improvements in VO2max and performance was noted [15]. The present study 
displays similar results with equal VO2peak in hyperoxia and normoxia both before and after the 
hyperoxic training intervention. The lack of improvement in VO2peak in hyperoxia may be a result 
of decreased leg blood flow. In a study by Russell and colleagues [19], a trend towards reduced 
leg blood flow was observed despite of no change in haemoglobin oxygen saturation. In the 
present study, in which SpO2 was significantly increased during hyperoxic testing, one might 
suggest that leg blood flow may significantly be reduced resulting in no additional oxygen 
delivery to the working skeletal muscles serving as an explanation for absence of additional 
oxygen consumption in hyperoxia and the lack of effect from hyperoxic training. This could 
explain the deficiency of accumulative effect of hyperoxia on VO2peak and stroke volume over 
time with aerobic interval training despite increased haemoglobin oxygen saturation and the 
theoretical possibility of increased oxygen delivery to the working muscles.  
 
Increased training work load has been reported during hyperoxic training in previous studies [11, 
13]. In those training studies in healthy subjects hyperoxic exposure enabled the subjects to 
increase the training work load by 8-9% at the normoxic training heart rate. Despite increased 
training work load hyperoxic training was not found to be superior in terms of VO2max and 
performance enhancement [11, 13]. This is in line with the present study where no difference 
was found between the effects of interval training in hyperoxia and normoxia. In the study by 
Ploutz-Snyder et al [13] the lack of improvement in VO2max after hyperoxic training may be 
explained by the relatively low training intensity (70% of maximal heart rate), while intensity 
levels above 85% of peak heart rate was used by Perry et al [11] and in the present study, and 
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thereby should be optimal for detecting any effects of hyperoxic training on stroke volume and 
VO2peak [18, 24].  
 
The notion in this experiment was that the ability of CAD patients` muscles to increase the a-vO2 
difference as shown in a study of intermittent claudication patients [21] would enable the patients 
to utilize the extra 3% arterial oxygen saturation during training leading to a cumulative positive 
effect on both workload and training response during the 30 interval sessions. As this did not 
happen, other explanations may be that the a-vO2 difference did not change fast enough to pick 
up the advantage of extra oxygen. However, great changes in a-vO2 difference has been shown in 
previous experiments [16] and may not be the most likely cause. The most probable reason for 
the lack of improved training effect from a higher arterial oxygen saturation is that hyperoxic 
exercise, despite higher blood oxygen carrying capacity, does not increase the exercise induced 
load on the heart compared to normoxic training conditions. Thereby the main limiting factor for 
VO2peak, namely, the stroke volume of the heart changed to the same degree in the two training 
groups. One may speculate that the improvement in stroke volume in the two groups improves 
the blood and oxygen supply to the working muscles to a similar extent as the improvement in 
the muscles ability to utilize oxygen since no additional affect of hyperoxia was detected at post 
testing. Since the difference between normoxic and hyperoxic training is arterial oxygen content 
and not cardiac output or shear stress in the blood supply chain, these findings seem to support 
Wagner’s [22] notion that the oxygen supply is of the greater importance than the demand for 
oxygen in terms of explaining training induced changes.   
 
Despite the lack of  difference in the training response between normoxic and hyperoxic training, 
a substantial improvement in VO2peak following 30 interval sessions using 4x4 minutes interval 
training at 85 to 95 % of maximal heart rate was found. The 16–17% improvement in VO2peak 
confirms that aerobic interval training at 85-95% of HRpeak is highly effective for improving 
VO2peak and stroke volume in coronary artery disease patients [4, 18].  
 
No significant change in total blood-or plasma volume was observed from pre to post training in 
the HT in the present study (table 5). Red blood cell mass was, however, significantly decreased 
after exercise. The findings in the present study differ from the data of the studies reporting long 
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term changes in plasma volume with aerobic exercise [23], but in line with others having found 
no change [2, 5]. A reduced red cell mass could decrease the oxygen carrying capacity of the 
blood, and thereby could not explain the improved VO2peak in this experiment.  
 
In the present study the HT group displayed a significant improvement in peak heart rate and 
lactate concentration from pre to post training. Both the HT and the NT training groups improved 
peak ventilation from pre to post training as expected from improvements in VO2peak. The HT 
group did however improve ventilation to a greater extent than the NT group. Improvements in 
these variables in the HT group may be a result of a greater motivation to push through to 
exhaustion during VO2peak post testing. Part of the increased heart rate may be due to atria 
fibrillation during exercise, and not a true difference in exertion during pre and post testing. In 
the NT group significant increase in self reported perceived exertion from pre to post training 
may be a factor of patients adjusting their perception of exercise strain over the course of the 
training intervention. Despite differences between the groups at the pretesting point in the Borg 
scale, no significant difference in R values was noted between the groups or in any of the 
exercise groups between the pre and the post tests. This implies that the level of strain and 
hyperventilation was equal between the tests. Therefore, change in the perceived exertion was 
not an effect of greater level of exhaustion in the post test, but a factor of the patients’ 
interpretation of the scale.  
 
In the present study breathing 100% oxygen enriched air during high intensity aerobic interval 
training improves VO2peak to the same extent as ambient air training in stable coronary artery 
disease patients with mild to moderate coronary ischemic response to exercise.  
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Table 1 Physical characteristic of the subjects at inclusion  
 Hyperoxic training group 
(n=8) 
Normoxic training group 
(n=10) 
Men/women   6/2 7/3 
Age (years)  61.1 ± 7.1              63.6 ± 6.5 
Stature (cm)  175.5 ± 11.1            173.4 ± 9.2 
Body mass (kg)   82.3 ± 13.2   79.3 ± 12.2 
Body mass index (kg . m-2) 27.2 ± 2.8 26.3 ± 2.6 
Systolic blood pressure (mmHg) 130 ± 27 139 ± 20 
Diastolic blood pressure (mmHg)   77 ± 10                 84 ± 8 
Coronary artery disease   
   Myocardial infarction  1 3 
   Percutaneous coronary intervention  4 4 
   Coronary artery bypass surgery  5 3 
 
Table 2 Peak metabolic data in normoxia before and after training 
 Hyperoxic training group  
(n=8) 
Normoxic training group  
(n=10) 
  Before After Before After 
Oxygen uptake      
   L•min-1    2.11 ± 0.35   2.44 ± 0.48 *   2.17 ± 0.53 2.53 ± 0.61* 
   mL•kg-1•min-1  25.9 ± 4.2 29.9 ± 3.9 *   27.3 ± 4.6    31.8 ± 5.0* 
   mL•kg-0.75•min-1   77.7 ± 11.3   89.6 ± 11.6 * 81.4 ± 14.4 94.8 ± 16.1* 
Heart rate (beats•min-1)  141 ± 19 152 ± 19 *    163 ± 19     160 ± 19 
Ventilation (BTPS) (L•min-1)   72.6 ± 14.4    87.3 ± 19.2 *#   86.1 ± 19.8 92.7 ± 24.2* 
Respiratory exchange ratio    1.11 ± 0.08     1.20 ± 0.10   1.14 ± 0.06    1.15 ± 0.07 
Work load (watt) 123 ± 27      159 ± 37 *    155 ± 38     204 ± 21* 
Arterial oxygen saturation (%)         95 ± 3        95 ± 3 - - 
Lactate (mmol•L-1)   3.61 ± 1.01   6.90 ± 1.57 *  4.30 ± 1.20    6.23 ± 1.80 
Borg scale 18 ± 1**        18 ± 1      15 ± 2       17 ± 1*#
Data are presented as mean ± SD for each variable.  
* Significant difference between pre and post tests within exercise groups (p < 0.05) 
** Significant  difference between groups at pre test time point  
# Significant difference between groups (p < 0.05) 
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Table 3 Peak cardiac function at 80% of VO2peak work load before and after training 
 Hyperoxic training group  
(n=8) 
Normoxic training group  
(n=10) 
 Before After Before After 
Heart rate           (beat•min-1)     112 ± 11      125 ± 14 *     127 ± 19      133 ± 19 
Cardiac output    (L•min-1)    11.0 ± 2.1     14.1 ± 2.3 *    12.1 ± 2.6     14.9 ± 3.5* 
Stroke volume    (mL•beat-1)   98.9 ± 18.9   114.2 ± 21.3 *    95.5 ± 20.8   112.2 ± 21.1* 
* Significant difference between pre and post tests within exercise groups (p < 0.05) 
 
Table 4 Peak metabolic data from hyperoxic testing in the hyperoxic training group (n = 8) 
 Before  After  
Oxygen uptake   
    L•min-1 2.07 ± 0.35          2.41 ± 0.43 
    mL•kg-1•min-1           25.3 ± 4.0          29.7 ± 4.0 
    mL•kg-0,75•min-1 76.0 ± 11.3          88.9 ± 11.0 
Heart rate (beats•min-1)            140 ± 21           151 ± 17 
Ventilation (BTPS) (L•min-1) 55.5 ± 10.4          69.5 ± 10.4 
Respiratory exchange ratio  0.96 ± 0.03 1.15 ± 0.14†
Work load (watt)         121.0 ± 34.3        158.7 ± 34.2 
Arterial oxygen saturation (%)               98 ± 2             98 ± 3 † 
Lactate (mmol•L-1) 2.50 ± 1.06          5.71 ± 2.14 
Borg scale              18 ± 2             18 ± 2 
Data are presented as mean ± SD for each variable.  
† Significant differences between normoxic and hyperoxic tests (p < 0.05) 
 
Table 5 Blood volume before and after training in the hyperoxic training group (n = 8) 
 Before After 
Blood volume (L)           4.28 ± 0.67                  4.25 ± 0.71 
Plasma volume (L)           2.81 ± 0.36                  2.87 ± 0.42 
Red cell mass (L)           1.47 ± 0.34  1.39 ± 0.32 * 
Blood volume (mL•kg-1)         52.29 ± 8.74                52.23 ± 7.60 
Plasma volume (mL•kg-1)         34.47 ± 5.69                35.21 ± 4.94 
Red cell mass (mL•kg-1)         17.81 ± 3.69                17.01 ± 3.26 * 
Hematocrit (%)           39.1 ± 3.5                  37.3 ± 3.1 * 
* Significant difference between pre and post tests (p < 0.05) 
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Figure 1. 
 % change in VO2peak (L • min-1) and peak stroke volume (mL • stroke-1) from pre and post 
training for the hyperoxic and normoxic training groups presented as mean ± SE. Significant 
difference within groups from pre to post training; * = p < 0.05   
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166. John-Anker Zwart: LUMBAR NERVE ROOT COMPRESSION, BIOCHEMICAL AND 
NEUROPHYSIOLOGICAL ASPECTS. 
167. Geir Falck: HYPEROSMOLALITY AND THE HEART. 
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234. Arne Wibe: RECTAL CANCER TREATMENT IN NORWAY – STANDARDISATION OF 
SURGERY AND QUALITY ASSURANCE 
2004 
235. Eivind Witsø: BONE GRAFT AS AN ANTIBIOTIC CARRIER 
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ADOLESCENTS:  CHARACTERISTICS AND PSYCHOLOGICAL MANAGEMENT OF 
PATIENTS IN OUTPATIENT PSYCHIATRIC CLINICS 
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259. Vegard Heimly Brun:  ROUTES TO SPATIAL MEMORY IN HIPPOCAMPAL PLACE CELLS 
260. Kenneth McMillan:  PHYSIOLOGICAL ASSESSMENT AND TRAINING OF ENDURANCE 
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